Nivolumab in Preventing Colon Adenomas in Participants With Lynch Syndrome and a History of Partial Colectomy
Conditions: Colon Adenoma; Colon Carcinoma; Lynch Syndrome; MLH1 Gene Mutation; MSH2 Gene Mutation Intervention: Biological: Nivolumab Sponsors: Joanne Jeter; National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials